Intravenous Ketamine for Cancer Pain Management, Including Flares During the COVID-19 Pandemic: A Retrospective Study

OBJECTIVES: Cancer-related neuropathic pain (CNP) affects an increasing proportion of cancer patients, given improved survival, but it remains difficult to treat. There are no studies on an extended intravenous ketamine protocol and its synergies with common neuropathy treatments to treat CNP. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Daniel, Haffey, Paul, Patel, Ankur, Gulati, Amitabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Cancer Pain & Palliative Care Section
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195210/
https://www.ncbi.nlm.nih.gov/pubmed/34086927
http://dx.doi.org/10.1093/pm/pnab163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195210/
https://www.ncbi.nlm.nih.gov/pubmed/34086927
http://dx.doi.org/10.1093/pm/pnab163

Ejemplares similares